Clinical Trials Browser

Phase 1 × Recruiting × Androgen Antagonists × Clear all

NCT07570979 2026-05-06

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

Phase 1 Recruiting

Prostatic Neoplasms